Sens. Joseph Lieberman (D-Conn.) and Orrin Hatch (R-Utah) in the next few months plan to propose legislation to provide pharmaceutical companies that develop products used to respond to a bioterrorist ...

House leaders are leaning toward adopting the Senate version of legislation enacting Project Bioshield, according to House and Senate aides -- a move that would accelerate passage of a measure to ...

IT IS EXCEEDINGLY rare these days to find something that the House and the Senate, the Republicans and the Democrats, can all agree on. But after the Senate's final passage of the Project Bioshield ...

Please join the CSIS Bipartisan Alliance for Global Health Security on Thursday, July 11 from 5:00 to 6:00 PM ET for a broadcast roundtable discussion on the occasion of the 20th anniversary of ...

Rep. Tom Davis (R-Va.), chairman of the House Government Reform Committee, requested information Dec. 5 from Michael Leavitt, secretary of the Department of Health and Human Services, regarding ...

Few would argue the United States, or any country for that matter, was prepared for the covid-19 pandemic, even though, starting in 2003, the U.S. devoted $5.6 billion to fund Project Bioshield, ...

WASHINGTON, DC (April 4, 2003): Biotechnology companies are well suited to address the modest commercial opportunities offered by creating safer, more effective and less costly vaccines for biodefense ...

With Bush expected to sign the bill creating Project BioShield, the United States "will shortly unleash the greatest force in world history: American ingenuity," Rep. Christopher Cox (R-Calif.), ...

WASHINGTON — Repeatedly invoking the threat of terrorism, the Senate on Wednesday unanimously approved a $5.6-billion, 10-year initiative to encourage private industry to develop vaccines and drugs ...

SAN DIEGO - When President Bush signed Project BioShield into law in July, he said he was immediately making $5.6 billion available to counter such anticipated threats as smallpox genetically ...